Bank of America’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,600
Closed -$55K 8096
2014
Q4
$55K Sell
1,600
-2,900
-64% -$94.6K ﹤0.01% 6289
2014
Q3
$134K Buy
4,500
+1,000
+29% +$21.2K ﹤0.01% 5768
2014
Q2
$70K Buy
3,500
+2,300
+192% +$52.8K ﹤0.01% 6404
2014
Q1
$33K Sell
1,200
-39,200
-97% -$1.04M ﹤0.01% 6666
2013
Q4
$838K Buy
40,400
+5,500
+16% +$104K ﹤0.01% 4264
2013
Q3
$635K Sell
34,900
-117,100
-77% -$2.12M ﹤0.01% 4410
2013
Q2
$2.53M Buy
+152,000
New +$2.43M ﹤0.01% 2944

Other funds holding AUXL

Bank of America's AUXL Position: Q1 2015 in Review

Bank of America sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 63,716 shares — an estimated $2.19M sold.

Bank of America first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $8.92M in Q1 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • Bank of America reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Bank of America sold 63,716 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $2.19M.
  • Bank of America first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Bank of America's AUXILIUM PHARAMCEUTICALS INC position peaked at $8.92M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Bank of America's 13F filing for Q1 2015, filed 15 May 2015.